← Leaderboards
David Allenberg Katzenstein
Stanford University
$5,157,240
Attributed
$7,282,037
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,282,037 · 10
By mechanism
R01$4,805,705 · 2
R21$1,134,626 · 3
U2R$747,321 · 1
R03$317,500 · 2
D43$276,283 · 1
M01$602 · 1
Top collaborators
- Rami Kantor8 shared
- Shungu Munyati1 shared
Most similar at Stanford University
Same institution · by research overlap
- Matthew S Bogyo$24,780,518
- Miriam B Bischoff$1,826,470
- Rami Kantor$14,799,482
- Meredith Lauren Carpenter$2,557,536
- Adina Paytan$8,362,578
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesMutationResistancePharmaceutical PreparationsDrug ResistanceBaseFailure (Biologic Function)SamplingVirusVariantDesignHiv-1Antiretroviral TherapyInfectionEpidemicPlasmaAnti-Retroviral AgentsResistance MutationLifeCaringCollaborationsInternationalFrequencies (Time Pattern)Public Health Relevance
Grant awards (26)
Advanced Training in Community Based Research; training in Bio-informatics, Drug Resistance and Pathogenesis$276,283
D43 · FY2020 · TW · contact PI
New Mechanisms of Protease Inhibitors Resistance$80,250
R03 · FY2016 · AI · contact PI
New Mechanisms of Protease Inhibitors Resistance$80,250
R03 · FY2015 · AI · contact PI
HIV Drug Resistance Monitoring in Chennai, India$210,381
R21 · FY2014 · AI
Virologic Failure of boosted Proteases$196,250
R21 · FY2014 · AI · contact PI
Decay rate of archived HIV-1 drug resistance mutations$78,500
R03 · FY2014 · AI · contact PI
Virologic Failure of boosted Proteases$221,370
R21 · FY2013 · AI · contact PI
HIV Drug Resistance Monitoring in Chennai, India$206,875
R21 · FY2013 · AI
Decay rate of archived HIV-1 drug resistance mutations$78,500
R03 · FY2013 · AI · contact PI
HIV-1 Drug Resistance in Different Subtypes$622,828
R01 · FY2012 · AI · contact PI
HIV-1 Drug Resistance in Different Subtypes$811,418
R01 · FY2011 · AI · contact PI
HIV-1 Drug Resistance in Different Subtypes$119,000
R01 · FY2011 · AI · contact PI
HIV-1 Drug Resistance in Different Subtypes$639,331
R01 · FY2010 · AI · contact PI
HIV-1 Drug Resistance in Different Subtypes$626,417
R01 · FY2009 · AI · contact PI
African Programe for Training in HIV/TB Research$117,314
U2R · FY2009 · TW · contact PI
HIV-1 Drug Resistance in Different Subtypes$737,062
R01 · FY2008 · AI · contact PI
Drug Resistance and Pathogenesis in Subtype C HIV-1$310,675
R01 · FY2008 · AI · contact PI
African Programe for Training in HIV/TB Research$122,197
U2R · FY2008 · TW · contact PI
Drug Resistance and Pathogenesis in Subtype C HIV-1$316,692
R01 · FY2007 · AI · contact PI
African Program for Research training in HIV, TB and associated opportunistic inf$114,863
U2R · FY2007 · TW · contact PI
Drug Resistance and Pathogenesis in Subtype C HIV-1$326,151
R01 · FY2006 · AI · contact PI
African Programe for Training in HIV/TB Research$145,314
U2R · FY2006 · TW · contact PI
Drug Resistance and Pathogenesis in Subtype C HIV-1$296,131
R01 · FY2005 · AI
African Programe for Training in HIV/TB Research$247,633
U2R · FY2005 · TW
VERTICAL TRANSMISSION OF SUBTYPE C HIV IN ZIMBABWE$299,750
R21 · FY2001 · AI
ACTIVITY OF SQVSGC IN COMBINATION IN HIV INFECTED SUBJECTS$602
M01 · FY2000 · RR